Login
Toggle navigation
Videos
Categories
Trending
ClearVue Technologies Ltd CEO Basil Karampelas discusses his new role as North American leader in an interview with Proactive.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Chuck Mowrey. CEO and President North America
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
PYX Resources' Export License and Its Role in Strengthening EBITDA | Oliver Hasler, CEO , PYX Resources Ltd.
00:10:00
ABM CEO and Kevin O'Leary Analyze Labor Market on 'Squawk Box | Scott Salmirs - President and Chief Executive Officer, ABM Industries Incorporated
00:10:00
Best Fundraising Tips For Media Startups And Entrepreneurs|Aniq Rahman,Managing Partner,Vast Ventures
00:10:00
Profitability with sustainability is the key to win|Ben Kortlang,Co-founder and Partner,G2 Venture Partners
00:10:00
Southern Gold: Focused Growth and Investor Value - Insights from One-to-One Mining Conference
00:10:00
Venture cap is quite popular now a days|Koichiro Nakamura,founder,Sozo Ventures
00:10:00
Legacy Minerals Uncovers Untapped Potential in New South Wales with Major Partnerships and Promising Drill Results
00:00:00
J. Michael McWilliams, MD, PhD, Professor of HMS | Supporting Equity in Health Care Systems
00:10:00
Jerry Lombard on Leading Janney Montgomery Scott: A 200-Year Legacy and Growth
00:10:00
Adani Group's Karan Adani at the Terminal 3 Inauguration at Lucknow Airport: A Significant Milestone | Rajesh Adani, Managing Director, Adani Enterprises Ltd
00:10:00
ActiveOps IPO: CEO Richard Jeffery on the Business Model and Market Potential | Richard Jeffery, CEO, ActiveOps Plc.
00:10:00
UiPath Co-CEO Robert Enslin discusses the future of workplace automation with Assistant Managing Editor Diane Brady.